Entrance of the Sky Lakes Collaborative Health Center, which will serve south-central Oregon and is a collaboration between area health care professionals and OHSU students and resident-physicians. The $50 million project is expected to be completed in late 2019 and open for business in 2020. (Rendering courtesy of Sky Lakes Medical Center)

West view of the Sky Lakes Collaborative Health Center, which will serve south-central Oregon and is a collaboration between area health care professionals and OHSU students and resident-physicians. The $50 million project is expected to be completed in late 2019 and open for business in 2020. (Rendering courtesy of Sky Lakes Medical Center)

A ceremonial groundbreaking was held for the new Sky Lakes Collaborative Health Center in Klamath Falls, Ore., May 30, 2018. The facility will serve south-central Oregon and is a collaboration between area health care professionals and OHSU students and resident-physicians. The $50 million project is expected to be completed in late 2019 and open for business in 2020. (OHSU/Kristyna Wentz-Graff)

El Center for Experimental Therapeutics del OHSU Knight Cancer Institute ofrece conocimiento experto en farmacología, toxicología y química para el desarrollo de nuevos fármacos, junto con acceso a compuestos químicos, servicios de detección de alto rendimiento y una amplia gama de sistemas de prueba modelo. (OHSU/Christine Torres Hicks)

(De izquierda a derecha) Dhanir Tailor, Ph.D., Sanjay Malhotra, Ph.D. y Arpit Dheeraj, Ph.D. se encuentran entre los desarrolladores del primer fármaco que se dirige a YB-1, un importante punto de señalización en muchos tipos de cáncer diferentes. El fármaco ha demostrado una potente actividad antitumoral en modelos animales de varios tipos de tumores diferentes. (OHSU/Christine Torres Hicks)

Oregon State Elks members Jerry Sherman (left), Frank Hise (center left) and Ted Hurd (far right) present OHSU’s Kenneth Swan, M.D., (center right) with a check in this undated archive photo. (OHSU)